Press Releases

WASHINGTON, Aug. 22, 2019 /PRNewswire/ -- Inc. magazine today announced that ProSource360 Consulting Services is No. 515 on its annual Inc. 5000 list, the most prestigious ranking of the nation's fastest-growing private companies.

PITTSBURGH, Aug. 22, 2019 /PRNewswire/ -- Ebb Therapeutics, a med-tech start-up that develops innovative products designed to help the sleep-deprived millions, announces that its added Eduard Röösli as its new President & CEO, effective immediately.

SALT LAKE CITY, Aug. 22, 2019 /PRNewswire/ -- As a leader in the health and wellness industry, USANA strives to continuously develop products featuring new, cutting-edge formulations. During its annual Global Convention in Salt Lake City, USANA launched an innovative oral care line consisting of two products— the

SAN CARLOS, Calif., Aug. 22, 2019 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced that it has now processed

CORONA, Calif., Aug. 22, 2019 /PRNewswire/ -- GP Solutions (OTC:GWPD), a leading developer of automated micro-farms called "GrowPods," was named a top cannabis stock pick by

NORTH READING, Mass., Aug. 22, 2019 /PRNewswire/ -- TraceLink Inc., the world's largest integrated digital supply network, providing real-time information sharing for better patient outcomes, today announced financial and company results for the second quarter of 2019.

STAMFORD, Conn., Aug. 22, 2019 /PRNewswire/ -- According to the American Cancer Society, prostate cancer is the second most commo

SAN DIEGO, Aug. 22, 2019 /PRNewswire/ -- Snap Bio, Inc., a preclinical oncology company, today announced that its lead drug candidate, SNP-162, has been found to effectively overcome disabling drug-resistance and represents a new treatment for recurrent advanced and metastatic liver cancer.  In collaboration with the Institute of Biomedical Research of

STEVENS, Pa., Aug. 22, 2019 /PRNewswire/ -- As a Medicare and Medicaid certified facility, The Gardens at Stevens is required to meet over 180 regulatory standards intended to protect residents. However, facilities vary in the quality of care and services they provide residents. The Gardens at Stevens

THOUSAND OAKS, Calif., Aug. 22, 2019 /PRNewswire/ -- Amgen (NASDAQ:AMGN) and Allergan plc. (NYSE:AGN) today announced positive top-line results from a comparative clinical study evaluating the efficacy and safety of ABP 798, a biosimilar candidate to Rituxan® (rituximab), compared to Rituxan in patients with CD20-positive B-cell non-Hodgkin